About
Technology
Issues
FAQ
Links
Official Page
SGLT-2 inhibitors and cardiovascular risk: Proposed pathways and review of ongoing outcome trials
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.